COVID-19 vaccination in Japan


== COVID-19 Vaccination in Japan ==
The COVID-19 vaccination in Japan is part of the global effort to combat the COVID-19 pandemic. The vaccination campaign in Japan began in February 2021, following the approval of the Pfizer-BioNTech COVID-19 vaccine by the Ministry of Health, Labour and Welfare (MHLW).
Vaccines Approved[edit]
As of 2023, Japan has approved several vaccines for emergency use, including:
- Pfizer-BioNTech COVID-19 vaccine
- Moderna COVID-19 vaccine
- AstraZeneca COVID-19 vaccine
- Novavax COVID-19 vaccine
Vaccination Rollout[edit]
The vaccination campaign was rolled out in phases, prioritizing healthcare workers, the elderly, and individuals with underlying health conditions. The general population became eligible for vaccination in mid-2021. The MHLW coordinated with local governments to set up mass vaccination centers and utilized existing healthcare facilities to administer the vaccines.
Challenges[edit]
Japan faced several challenges during the vaccination rollout, including:
- Initial vaccine supply shortages
- Logistical issues in distribution
- Vaccine hesitancy among certain segments of the population
Public Response[edit]
Public response to the vaccination campaign has been mixed. While a significant portion of the population has been vaccinated, there has been some vaccine hesitancy due to concerns about side effects and the rapid development of the vaccines.
Impact[edit]
The vaccination campaign has had a significant impact on controlling the spread of COVID-19 in Japan. It has contributed to a decrease in the number of severe cases and hospitalizations, allowing for the gradual lifting of restrictions and the reopening of the economy.
Related Pages[edit]
- COVID-19 pandemic in Japan
- COVID-19 vaccine
- Ministry of Health, Labour and Welfare (Japan)
- Pfizer-BioNTech COVID-19 vaccine
- Moderna COVID-19 vaccine
- AstraZeneca COVID-19 vaccine
- Novavax COVID-19 vaccine
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
